Research Insight
Cytheris announces results of phase IIa study indicating that...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced results of a multi-center Phase...
Research Insight
Progenics Reports Positive Preliminary Data from Ongoing Phase 1...
Progenics Pharmaceuticals, Inc.reported positive preliminary data from an ongoing phase 1 study of PSMA ADC, an antibody-drug conjugate (ADC) designed to selectively deliver chemotherapy to...
Research Insight
New potential drug targets discovered for preventing prostate cancer...
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth. Inhibition of...
Research Insight
Manhattan Research’s ePharma Consumer study provides in-depth info about...
Pharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study, which explores the online behaviors of ePharma Consumers, or U.S....
Research Insight
Ardea Biosciences Announces Positive Top-Line Results from Phase 2b...
Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b study of RDEA594 in combination with the current standard of care for the...
Research Insight
Pro-Pharmaceuticals and Mount Sinai annouced New Liver Fibrosis Research...
Pro-Pharmaceuticals, Inc., the leading developer of Galectin therapeutics to treat cancer and fibrosis, today announced it has entered into a new research collaboration with Mount...
Research Insight
New data show potential for Novartis Meningitis B vaccine...
New data demonstrated that antibodies induced by Novartis Vaccines investigational, four component, Meningococcal Serogroup B Vaccine (4CMenB) killed the majority of a collection of geographically...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.